PENEDERM NDAs FOR RETINOIC ACID GEL AND CREAM FOR ACNE
This article was originally published in The Tan Sheet
Executive Summary
PENEDERM NDAs FOR RETINOIC ACID GEL AND CREAM FOR ACNE have been filed with FDA, the company stated in a May 2 "red herring" prospectus for the offering of 1.7 mil. shares of common stock by Penederm shareholders. Foster City, Calif.-based Penederm said that Phase III trials that enrolled about 400 subjects were completed in the summer of 1993, and both NDAs for the prescription products were originally submitted in September.